Intramedullary Nailing for Femoral Shaft Fractures

November 16, 2026 updated by: Roman M. Natoli, Indiana University

Comparative Effectiveness Randomized Controlled Trial of Micromotion vs Non-micromotion Intramedullary Nailing for Femoral Shaft Fractures

A randomized controlled trial that is trying to find the best treatment for a severe upper leg (i.e., thigh, also known as femoral shaft) fracture. One type of treatment, which is called micromotion intramedullary (within the hollow center of the bone) nailing, is a type of nail used for thigh fracture treatments that helps to heal the bone by allowing a small amount of controlled movement. Another type, called non-micromotion intramedullary nailing, is also used to treat thigh fractures but does not include this controlled-movement feature. Both treatments are approved by the FDA but have not been directly compared to each other. Participation includes being assigned to receive either a micromotion intramedullary nail or a non-micromotion intramedullary nail. Those that participate will be randomly assigned (like a flip of a coin) to one of those treatment methods and return for standard follow-up visits. In addition to those regular clinical follow-ups, participants will complete some brief surveys/questionnaires while they are in the hospital. Research staff will also look at past medical history.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

290

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Recruiting
        • Indiana University Health Methodist Hospital
        • Principal Investigator:
          • Roman Natoli, MD, PhD
        • Contact:
          • Cora F Mizimakoski, Bachelor of Science
          • Phone Number: 317-963-5034
          • Email: cmizimak@iu.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 18-84 years old inclusive with a femoral shaft fracture deemed appropriate for treatment with an IMN by the treating surgeon

Exclusion Criteria:

  • Not within age range
  • Planned treatment with dominant implants other than IMN
  • Non-ambulatory at baseline
  • Fracture needs a planned-staged secondary procedure for bone defects (e.g., Masquelet)
  • Any previous surgery on the index site
  • Fracture fixation >28 days from injury
  • Fractures that the treating surgeon indicates require any additional fixation that spans the fracture. These patients will be late ineligible
  • Patients with a history of infection or a current active infection at the surgical site
  • Patients undergoing revision surgery following primary fixation
  • Patients undergoing femoral nailing for a pathological fracture
  • Patients undergoing bone transport over an intramedullary nail
  • Non-English or Non-Spanish speaking
  • Prisoners or impending incarceration
  • Patients unwilling or unable to participate in study protocol or follow up in the IU system for 12 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Intramedullary Nailing

A rod inserted into the hollow center of a long bone to hold a broken bone in place while it heals.

Experimental: OrthoXel Micromotion Intramedullary Nail

An intramedullary nail that allows for controlled axial micromotion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Superiority of micromotion nailing over non-micromotion IMN according to a composite outcome using a win ratio reflective of improved femoral shaft fracture healing
Time Frame: From enrollment to end of treatment at about a year.
From enrollment to end of treatment at about a year.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Iindividual levels of the win-ratio pyramid between the micromotion nailing and non-micromotion nailing groups.
Time Frame: From enrollment to end of treatment at about a year.
From enrollment to end of treatment at about a year.
Superiority of micromotion nailing in a subgroup of patients at high baseline risk for nonunion.
Time Frame: From enrollment to end of treatment at about a year.
From enrollment to end of treatment at about a year.
Number of patients with Adverse Events and Complications between the Micromotion nail and standard of care intramedullary nails.
Time Frame: From enrollment to end of treatment at about a year.
From enrollment to end of treatment at about a year.
Change in daily step count from pre-injury baseline between the micromotion nailing and non-micromotion nailing groups.
Time Frame: From enrollment to end of treatment at about a year.

Daily step count, measured in steps per day, will be obtained from the Apple Health app on the participant's iPhone. Participants will download the OrthoSteps app once to transfer their Apple Health data to the study team. Step counts will be assessed at the pre-injury baseline and at each post-injury follow-up.

From enrollment to end of treatment at about a year.
Gait balance between the two groups as calculated by the GaitMap.
Time Frame: From enrollment to end of treatment at about a year
From enrollment to end of treatment at about a year
Walking speed using a GaitMap
Time Frame: From enrollment to end of treatment at about a year.
From enrollment to end of treatment at about a year.
Modified Radiographic union scores for femoral shaft fractures
Time Frame: From enrollment to end of treatment at about a year.
From enrollment to end of treatment at about a year.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Roman Natoli, MD, PhD, Indiana University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2026

Primary Completion (Estimated)

September 1, 2031

Study Completion (Estimated)

September 1, 2031

Study Registration Dates

First Submitted

August 26, 2026

First Submitted That Met QC Criteria

November 16, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 16, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 29753

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.